Cargando…

Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?

The emergence of multi-drug resistant bacteria has undermined our capacity to control bacterial infectious diseases. Measures needed to tackle this problem include controlling the spread of antibiotic resistance, designing new antibiotics, and encouraging the use of alternative therapies. Phage ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Rubio, Lorena, Jofre, Joan, Muniesa, Maite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745475/
https://www.ncbi.nlm.nih.gov/pubmed/29206153
http://dx.doi.org/10.3390/antibiotics6040032
_version_ 1783288910992900096
author Rodríguez-Rubio, Lorena
Jofre, Joan
Muniesa, Maite
author_facet Rodríguez-Rubio, Lorena
Jofre, Joan
Muniesa, Maite
author_sort Rodríguez-Rubio, Lorena
collection PubMed
description The emergence of multi-drug resistant bacteria has undermined our capacity to control bacterial infectious diseases. Measures needed to tackle this problem include controlling the spread of antibiotic resistance, designing new antibiotics, and encouraging the use of alternative therapies. Phage therapy seems to be a feasible alternative to antibiotics, although there are still some concerns and legal issues to overcome before it can be implemented on a large scale. Here we highlight some of those concerns, especially those related to the ability of bacteriophages to transport bacterial DNA and, in particular, antibiotic resistance genes.
format Online
Article
Text
id pubmed-5745475
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57454752018-01-02 Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy? Rodríguez-Rubio, Lorena Jofre, Joan Muniesa, Maite Antibiotics (Basel) Opinion The emergence of multi-drug resistant bacteria has undermined our capacity to control bacterial infectious diseases. Measures needed to tackle this problem include controlling the spread of antibiotic resistance, designing new antibiotics, and encouraging the use of alternative therapies. Phage therapy seems to be a feasible alternative to antibiotics, although there are still some concerns and legal issues to overcome before it can be implemented on a large scale. Here we highlight some of those concerns, especially those related to the ability of bacteriophages to transport bacterial DNA and, in particular, antibiotic resistance genes. MDPI 2017-12-05 /pmc/articles/PMC5745475/ /pubmed/29206153 http://dx.doi.org/10.3390/antibiotics6040032 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Rodríguez-Rubio, Lorena
Jofre, Joan
Muniesa, Maite
Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title_full Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title_fullStr Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title_full_unstemmed Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title_short Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
title_sort is genetic mobilization considered when using bacteriophages in antimicrobial therapy?
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745475/
https://www.ncbi.nlm.nih.gov/pubmed/29206153
http://dx.doi.org/10.3390/antibiotics6040032
work_keys_str_mv AT rodriguezrubiolorena isgeneticmobilizationconsideredwhenusingbacteriophagesinantimicrobialtherapy
AT jofrejoan isgeneticmobilizationconsideredwhenusingbacteriophagesinantimicrobialtherapy
AT muniesamaite isgeneticmobilizationconsideredwhenusingbacteriophagesinantimicrobialtherapy